Comcast Corporation (NASDAQ:CMCSA) promoted Lisa Bonnell to SVP and General Auditor

Comcast Corporation (NASDAQ:CMCSA) announced it has promoted Lisa Bonnell to Senior Vice President and General Auditor. In this role, she will lead the company’s internal audit function and oversee the performance for financial, operational and systems audits, among other responsibilities. She reports to the Audit Committee of the Board of Directors of Comcast Corporation and to Mike Cavanagh, Senior Executive Vice President and Chief Financial Officer, Comcast Corporation.

Comcast Corporation (NASDAQ:CMCSA) traded 12.27 Million shares and was closed at $70.92 per share. The current share price indicates that stock is -0.17% away from its one year high and is moving 37.79% ahead of its one year low. Stock monthly performance is recorded as 2.84% while its performance in last 5 sessions is 2.71%.

Analyst’s Analysis on Comcast Corporation (NASDAQ:CMCSA)

At the movement stock is under coverage by number of analysts. 11 given Buy rating to the stock whereas no analyst given UNDERPERFORM rating to stock and 2 analysts given HOLD rating. The consensus recommendation by Thomson Reuters analysts is Outperform and their mean rating for the stock is 1.67 on scale of 1-5. Analysts mean target price for Comcast Corporation (NASDAQ:CMCSA) is $76.46 while their mean recommendation is 1.80 (1=Buy, 5=sell).

Quest Resource Holding Corporation (NASDAQ:QRHC) shares moved to $2.32 after starting the day at $2.47 on Tuesday. Weekly volatility of QRHC is 9.20% and monthly volatility is 8.29%. Stock performance in last five sessions is recorded as -0.43% while year to date (YTD) performance is -5.31%. QRHC Gross Margin is 7.70% and its return on assets is -8.60%. Stock 3 months performance is recorded as 8.92%.

Analyst Rating on Quest Resource Holding Corporation (NASDAQ:QRHC)

Number of analysts are covering this stock and currently stock has got OUTPERFORM rating from 1 analyst of Thomson Reuters, no analyst given HOLD rating to the stock and 0 given UNDERPERFORM rating. Analyst’s mean target price for QRHC is $6.00 while analysts mean recommendation is 2.00.

LifeLock, Inc. (NYSE:LOCK) traded 1.08 Million shares and was closed at $23.96 per share. The current share price indicate that stock is -0.13% away from its one year high and is moving 162.14% ahead of its one year low. Stock monthly performance is recorded as 0.13% while its performance in last 5 sessions is 0.21%.

Analyst’s Analysis on LifeLock, Inc. (NYSE:LOCK)

At the movement stock is under coverage by number of analysts. At the movement stock is under coverage by number of analysts. 0 given Buy rating to the stock whereas no analyst given UNDERPERFORM rating to stock and 4 analysts given HOLD rating. The consensus recommendation by Thomson Reuters analysts is Hold and their mean rating for the stock is 3.17 on scale of 1-5. Analysts mean target price for LifeLock, Inc. (NYSE:LOCK) is $21.14 while their mean recommendation is 3.10 (1=Buy, 5=sell).

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) announced positive top-line results from the second of two pivotal phase 3 clinical trials evaluating the efficacy and safety of plecanatide, an investigational once-daily orally-administered compound, in 1,054 adult patients with irritable bowel syndrome with constipation (IBS-C).

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) shares moved to $6.77 after starting the day at $6.70 on Tuesday. Weekly volatility of SGYP is 6.07% and monthly volatility is 7.76%. Stock performance in last five sessions is recorded as 8.32% while year to date (YTD) performance is 11.17%. SGYP return on assets is -146.30%. Firm quarterly performance is 23.54%.

Analyst Recommendation on Synergy Pharmaceuticals Inc. (NASDAQ:SGYP)

Number of analysts are covering this stock and currently stock has got OUTPERFORM rating from 2 analysts of Thomson Reuters, 1 analyst given HOLD rating to the stock and 0 given UNDERPERFORM rating to Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) stock. Analyst’s mean target price for SGYP is $10.67 while analysts mean recommendation is 1.70.

Leave a Reply

Your email address will not be published. Required fields are marked *